Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Sonye K. Danoff et al.|The Lancet Respiratory Medicine|2022Cited by 211
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neckNicole G. Chau, Christopher A. French, Shelley Hurwitz et al.|Cancer|2016Cited by 210
Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical OutcomesJesmond Dalli, Rebecca M. Baron, Romain A. Colas et al.|Critical Care Medicine|2016Cited by 183
A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDSLaura E. Fredenburgh, Augustine M.K. Choi, Mark A. Perrella et al.|JCI Insight|2018Cited by 112
Outcome in middle-aged individuals with anomalous origin of the coronary artery from the opposite sinus: a matched cohort studyChristoph Gräni, Ronny R. Buechel, Philipp A. Kaufmann et al.|European Heart Journal|2017Cited by 71